HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Victor G Prieto Selected Research
Victor G Prieto Research Topics
Disease
113
Neoplasms (Cancer)
03/2024 - 02/2002
111
Melanoma (Melanoma, Malignant)
09/2023 - 02/2002
25
Neoplasm Metastasis (Metastasis)
03/2023 - 02/2002
18
Nevus (Nevi)
01/2023 - 05/2003
16
Carcinoma (Carcinomatosis)
02/2024 - 01/2006
15
Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2021 - 03/2006
8
Sarcoma (Soft Tissue Sarcoma)
11/2023 - 04/2003
7
Pigmented Nevus (Melanocytic Nevus)
11/2021 - 01/2002
7
Mycosis Fungoides
11/2019 - 04/2003
6
Merkel Cell Carcinoma
09/2022 - 04/2007
5
Breast Neoplasms (Breast Cancer)
03/2023 - 07/2009
5
Dermatitis
10/2020 - 02/2017
5
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2017 - 04/2003
5
Dysplastic Nevus Syndrome (Dysplastic Nevus)
03/2007 - 11/2003
4
Bullous Pemphigoid (Pemphigoid)
07/2023 - 08/2016
4
Cicatrix (Scar)
12/2022 - 08/2002
4
Skin Diseases (Skin Disease)
03/2022 - 12/2012
4
Lymphoma (Lymphomas)
05/2021 - 02/2007
4
Lymphatic Metastasis
03/2016 - 03/2002
4
Actinic Keratosis
07/2014 - 06/2008
4
Keratoacanthoma
07/2014 - 06/2008
4
Carcinogenesis
05/2010 - 04/2006
4
Renal Cell Carcinoma (Grawitz Tumor)
04/2010 - 05/2007
3
Blister (Bulla)
07/2023 - 08/2016
3
Disease Progression
03/2023 - 01/2009
3
Basal Cell Carcinoma (Rodent Ulcer)
01/2020 - 05/2008
3
Inflammation (Inflammations)
11/2019 - 01/2009
3
Keratosis
09/2019 - 02/2013
3
Necrosis
01/2019 - 08/2004
3
Hemangiosarcoma (Angiosarcoma)
06/2018 - 01/2013
3
T-Cell Lymphoma (Lymphoma, T Cell)
01/2018 - 01/2015
3
Exanthema (Rash)
12/2017 - 01/2009
3
Skin Neoplasms (Skin Cancer)
04/2012 - 12/2005
2
Residual Neoplasm
09/2022 - 04/2010
2
Hyperphosphatemia
03/2021 - 10/2018
2
Hyperpigmentation
05/2020 - 12/2015
2
Acrospiroma
08/2019 - 04/2010
2
Fever (Fevers)
01/2019 - 12/2016
2
Panniculitis
12/2017 - 08/2015
Drug/Important Bio-Agent (IBA)
25
Proteins (Proteins, Gene)
FDA Link
09/2023 - 10/2002
18
Biomarkers (Surrogate Marker)
IBA
11/2020 - 12/2006
15
Paraffin
IBA
11/2019 - 10/2002
13
Formaldehyde (Formol)
FDA Link
11/2019 - 10/2002
11
Immune Checkpoint Inhibitors
IBA
07/2023 - 01/2017
10
Antigens
IBA
01/2023 - 05/2007
9
Imatinib Mesylate (Gleevec)
FDA Link
04/2010 - 08/2002
7
Keratins (Keratin)
IBA
06/2023 - 03/2004
7
Monoclonal Antibodies
IBA
01/2023 - 02/2004
7
RNA (Ribonucleic Acid)
IBA
04/2021 - 08/2004
7
Vemurafenib
IBA
03/2016 - 12/2012
6
pembrolizumab
IBA
03/2023 - 08/2016
6
DNA (Deoxyribonucleic Acid)
IBA
11/2019 - 12/2009
5
Nivolumab
IBA
03/2023 - 08/2016
5
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2022 - 04/2003
5
S100 Proteins (S 100 Protein)
IBA
04/2021 - 05/2003
5
Messenger RNA (mRNA)
IBA
01/2021 - 10/2004
5
dabrafenib
IBA
09/2019 - 02/2013
5
Antibodies
IBA
09/2019 - 01/2006
5
Ligands
IBA
05/2019 - 01/2006
5
MART-1 Antigen
IBA
08/2017 - 07/2009
5
ErbB Receptors (EGF Receptor)
IBA
03/2014 - 12/2004
4
CTLA-4 Antigen
IBA
07/2018 - 01/2017
4
Transcription Factors (Transcription Factor)
IBA
03/2018 - 12/2005
4
Melanins (Melanin)
IBA
08/2017 - 01/2002
4
Sorafenib (BAY 43-9006)
FDA Link
03/2014 - 06/2008
4
Platelet-Derived Growth Factor
IBA
06/2011 - 04/2006
3
Collagen
IBA
11/2023 - 01/2002
3
Telomerase (Telomerase Reverse Transcriptase)
IBA
09/2023 - 01/2021
3
Ipilimumab
IBA
01/2021 - 01/2017
3
Estrogen Receptors
IBA
01/2021 - 10/2011
3
Cytokines
IBA
11/2019 - 05/2012
3
Anti-Bacterial Agents (Antibiotics)
IBA
01/2019 - 10/2004
3
MicroRNAs (MicroRNA)
IBA
11/2018 - 06/2013
3
Monophenol Monooxygenase (Tyrosinase)
IBA
09/2017 - 06/2014
3
Indicators and Reagents (Reagents)
IBA
11/2016 - 01/2011
3
Carcinoembryonic Antigen
IBA
06/2014 - 05/2009
3
Mucin-1 (CA 15-3 Antigen)
IBA
06/2014 - 10/2007
3
Hormones (Hormone)
IBA
01/2014 - 08/2004
3
Androgen Receptors (Androgen Receptor)
IBA
01/2014 - 09/2005
3
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
04/2007 - 01/2003
2
Myosins (Myosin)
IBA
03/2024 - 05/2008
2
Synaptophysin
IBA
06/2023 - 04/2007
2
relatlimab
IBA
03/2023 - 11/2022
2
Coloring Agents (Dyes)
IBA
09/2022 - 02/2014
2
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2022 - 08/2004
2
Cyclin D1
IBA
04/2021 - 04/2016
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
11/2020 - 02/2017
2
Paclitaxel (Taxol)
FDA Link
Generic
06/2018 - 03/2016
2
Brentuximab Vedotin
IBA
05/2018 - 12/2016
2
Eosine Yellowish-(YS) (Eosin)
IBA
01/2018 - 05/2009
2
Hematoxylin (Haematoxylon)
IBA
01/2018 - 05/2009
2
Vimentin
IBA
08/2017 - 10/2013
Therapy/Procedure
74
Therapeutics
01/2024 - 02/2002
10
Drug Therapy (Chemotherapy)
09/2022 - 10/2004
9
Aftercare (After-Treatment)
01/2021 - 08/2002
8
Immunotherapy
03/2023 - 08/2016
8
Radiotherapy
01/2016 - 03/2002
7
Lymph Node Excision (Lymph Node Dissection)
12/2019 - 07/2002
3
Neoadjuvant Therapy
03/2023 - 07/2018
2
Debridement
01/2019 - 10/2004